Alexza Pharmaceuticals, Inc. · Mountain View, CA United States (NASDAQ: ALXA)
| 2091 Stierlin Ct. | Phone: 650-944-7000 |
| Mountain View, CA | Fax: 650-944-7999 |
| 94043 | |
| United States | 
Map This Company |
Alexza Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Analytical Laboratory Instrument MfgCompany Description
Alexza Pharmaceuticals has found that its inhalation technologies can lead to swifter drug absorption. That is the basis for the company's primary product, Staccato inhalers, which it is developing to treat central nervous system (CNS) disorders. The inhalers contain a heating element coated with a thin layer of medicine. Before use, the patient triggers the heating element, which vaporizes the medicine, allowing the patient to inhale it. The medicine is then rapidly absorbed through the lungs at a rate typically faster than oral and intravenous applications. Alexza Pharmaceuticals targets neurological disorders including addiction and anxiety.
Alexza Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: ALXA Single Location |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 97 |
Executives
36 executives listed for Alexza Pharmaceuticals, Inc.'s Mountain View, CA location.
| President, CEO, and Director | Thomas King | |
|---|---|---|
| SVP, CFO, and General Counsel | August Moretti | |
| SVP Research and Development | James Cassella |